G蛋白耦连受体激酶在帕金森病发病机制中的研究进展
网络出版日期: 2011-08-29
基金资助
上海市科委基金(0952nm03700, 09JC1411000);上海市教委基金(10ZZ72);上海市白玉兰科技人才基金 (1009B097);国家自然科学基金(81071025)
Research progress of G protein-coupled receptor kinases in pathogenesis of Parkinson's disease
Online published: 2011-08-29
Supported by
Shanghai Science and Technology Committee Foundation, 0952nm03700, 09JC1411000;Shanghai Education Committee Foundation, 10ZZ72;Shanghai Baiyulan Science and Technology Talent Foundation,1009B097;National Natural Science Foundation of China, 81071025
吴 娜, 刘振国 . G蛋白耦连受体激酶在帕金森病发病机制中的研究进展[J]. 上海交通大学学报(医学版), 2011 , 31(8) : 1194 . DOI: 10.3969/j.issn.1674-8115.2011.08.032
G protein-coupled receptor kinases (GRKs) are a class of important soluble proteins that mediate receptor desensitization. They are the essential elements in negative feedback mechanism of G protein-coupled receptors (GPCRs) signaling pathway. Increased neurohormonal levels in nervous system diseases and adverse consequences in nervous system diseases induced by sustained neurohormonal stimulation indicate that the desensitization of neural receptors is a very important protection mechanism. Recent researches have revealed that GRKs play an important role in the development of Parkinson's disease and its motor complications. GRK6, which is localized in mediumsized spinous neurons, is the most critical GRKs in striatum. GRK6 knockout is related to the hypersensitivity of dopamine receptor. The research progress of GRKs in the pathogenesis of Parkinson's disease is reviewed in this paper.
/
〈 |
|
〉 |